Stellate Ganglion Block

Author

Michael Gofeld, M.D.
Assistant Professor
University of Washington School of Medicine

Commentary

Bernhard Moriggl, M.D.
Professor
Innsbruck Medical University
Innsbruck, Austria

Introduction - TOP

First described by Leriche in the 1930s,1 the stellate ganglion block (SGB) has been in use since that time without significant modification as a diagnostic and therapeutic intervention in chronic regional pain syndromes of the upper extremities2,3 as well as for a variety of medical conditions such as vascular insufficiency, post-herpetic neuralgia, phantom pain, vascular headache, cardiac arrhythmia, to name a few.4 

Read More >>